Clinical manifestations and management of cryptococcal infection

Journal of Postgraduate Medicine

Volumn 51, Issue 5, 2005, Pages

  Subramanian, S ^a   Mathai, D ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

AIDS; Amphotericin B; Cryptococcus; Fluconazole; Meningitis

Indexed keywords

ACETAZOLAMIDE; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CORTICOSTEROID; CYCLOSPORIN; FLUCONAZOLE; FLUCYTOSINE; FUNGISOME; GAMMA INTERFERON; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; PYRROLE DERIVATIVE; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BONE MARROW SUPPRESSION; CEREBROSPINAL FLUID ANALYSIS; CHILL; CLINICAL FEATURE; CLINICAL TRIAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DIARRHEA; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; ENDOPHTHALMITIS; EYE INFECTION; FEVER; FUNGAL DETECTION; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROPHOBICITY; INFECTION RISK; LABORATORY DIAGNOSIS; LUNG BIOPSY; LUNG INFECTION; MYCOLOGY; MYCOSIS; MYCOTIC MENINGITIS; NEPHROTOXICITY; OSTEOMYELITIS; PNEUMOCYSTIS PNEUMONIA; PROGNOSIS; RECURRENT DISEASE; REVIEW; RISK REDUCTION; SKIN DISEASE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CRYPTOCOCCOSIS; HUMANS; PROGNOSIS; RECURRENCE;

EID: 33645544832     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Kuroki M, Phichaichumpon C, Yasuoka A, Chiranairadul P, Chosa T, Sirinirund P, et al. Environmental isolation of Cryptococcus neoformans from an endemic region of HIV-associated cryptococcosis in Thailand. Yeast 2004;21:809-12.
2. Kwon-Chung KJ, Rhodes JC. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun 1986;51:218-23.
3. Brueske CH. Proteolytic activity of a clinical isolate of Cryptococcus neoformans. J Clin Microbiol 1986;23:631-3.
4. Granger DL, Perfect JR, Durack DT. Virulence of cryptococcosis: Regulation of capsule synthesis by carbon dioxide. J Clin Invest 1985;76:508-16.
5. Neilson JB, Fromtling RA, Bulmer GS. Cryptococcus neoformans: Size range of infectious particles from aerosolized soil. Infect Immun 1977;17:634-8.
6. Diamond RD, May JE, Kane MA, Frank MM, Bennett JE. The role of the classical and alternative complement pathways in host defense against Cryptococcus neoformans infection. J Immunol 1974;112:2260-70.
7. Krick JA. Familial cryptococcal meningitis. J Infect Dis 1981;143:133.
8. Perfect JR, Durack DT, Gallis HA. Cryptococcaemia. Medicine 1983;62:98-109.
9. Cohen J. Comparison of the sensitivity of three methods for the rapid identification of Cryptococcus neoformans. J Clin Pathol 1984;37:332-4.
10. Eng RH, Chmel H, Corrado M. The course of cryptococcal capsular polysaccharide antigenemia/human cryptococcal polysaccharide elimination kinetics. Infection 1983;11:132-6.
11. Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis. A study of 111 cases. Ann Intern Med 1974;80:176-81.
12. Aberg JA, Watson J, Segal M, Chang LW. Clinical utility of monitoring serum cryptococcal antigen titers in patients with AIDS-related cryptococcal disease. HIV Clin Trials 2000;1:1-6.
13. Fujita NK, Reynard M, Sapico FL, Guze LB, Edwards JE Jr. Cryptococcal intra cerebral mass lesions: the role of computed tomography and nonsurgical management. Ann Intern Med 1981;94:382-8.
14. Perfect JR. Cryptococcosis. In: Systemic Fungal Infections: Diagnosis and treatment II. Infect Dis Clin North Am 1989;3:77-102.
15. Kerkering TM, Duma RJ, Shadomy S. The evolution of pulmonary cryptococcosis: clinical implications from a study of 41 patients with and without compromising host factors. Ann Intern Med 1981;94:611-6.
16. Gal AA, Koss MN, Hawkins J, Evans S, Einstein H. The pathology of pulmonary cryptococcal infections in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1986;110:502-7.
17. Sabeta JR, Andriole VT. Cryptococcal infection of the central nervous system. Med Clin North Am 1985;69:333-44.
18. Steiner I, Polacheck I, Melamed E. Dementia and myoclonus in a case of cryptococcal encephalitis. Arch Neurol 1984;41:216-7.
19. Baker RD. The primary pulmonary lymph node complex of cryptococcosis. Am J Clin Pathol 1976;65:83-92.
20. Young EJ, Hirsh DD, Fainstein V, Willaims TW. Pleural effusions due to Cryptococcus neoformans: A review of the literature and report of two cases with cryptococcal antigen determination. Am Rev Respir Dis 1980;121:743-7.
21. Campbell DG. Primary pulmonary cryptococcosis. Am Rev Respir Dis 1966;94:236-43.
22. Rico MJ, Penneys NS. Cutaneous cryptococcosis resembling molluscum contagiosum in a patient with AIDS. Arch Dermatol 1985;121:901-2.
23. Glaser JB, Garden A. Inoculation of cryptococcosis without transmission of the acquired immunodeficiency syndrome. N Engl J Med 1985;313:266.
24. Crump JR, Elner SG, Elner VM, Kaufman CA. Cryptococcal endophthalmitis: case report and review. Clin Infect Dis 1992;14:1069-73.
25. Bayer AS, Choi C, Tillman DB, Guze LB. Fungal arthritis: V. Cryptococcal and histoplasmal arthritis. Semin Arth Rheum 1980;9:218-27.
26. Morris E, Wolinsky E. Localized osseous cryptococcosis: A case report J Bone Joint Surg 1965;47:1027-9.
27. Colmers RA, Irniger W, Steiberg DH. Cryptococcus neoformans endocarditis cured by amphotericin B. JAMA 1967;199:762-4.
28. Boden WE, Fisher A, Medeiros A, Benham I, McEnany MT. Bioprosthetic endocarditis due to Cryptococcus neoformans. J Cardiovasc Surg 1983;24:164-6.
29. Rigdon RH, Kirksey OT. Mycotic aneurysm (cryptococcosis) of the abdominal aorta. Am J Surg 1952;84:486-91.
30. Lewis N, Lipsick J, Cammarosano C. Cryptococcal myocarditis in acquired immunodeficiency syndrome. Am J Cardiol 1985;55:1240.
31. Rupali P, Subramanian S, Abraham OC, Mathai D. Disseminated histoplasmosis. In press.
32. Randall JE Jr, Stacy WK, Toone EC, Prout GR Jr, Madge GE, Shadomy HJ, et al. Cryptococcal pyelonephritis. N Engl J Med 1968;279:60-5.
33. Huynh MT, Reyes CV. Prostatic cryptococcosis. Urology 1982;20:622-3.
34. Procknow JJ, Benfield JR, Rippon JW, Diener CF, Archer FL. Cryptococcal hepatitis presenting as a surgical emergency. JAMA 1965;191:269-74.
35. Watson NE Jr, Johnson AH. Cryptococcal peritonitis. South Med J 1973;66:387-8.
36. Kovacs JA, Kovacs AA, Polis M, Wright WC, Gill VJ, Tuazon CU, et al. Cryptococcosis in acquired immunodeficiency syndrome. Ann Intern Med 1985;103:533-8.
37. Drutz DJ, Spickard A, Rogers DE, Koenig MG. Treatment of disseminated mycotic infections: A new approach to amphotericin B therapy. Am J Med 1968;45:405-18.
38. Kshirsagar NA, Kirodian BG. Liposomal Drug Delevery System from Laboratory to Patients: Our Experience Proc. Indian Natn Sci Acad 2002;B68:333-48
39. van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Eng J Med 1997;337:15-21.
40. Dupont B, Drouhet E. Cryptococcal meningitis and fluconazole. Ann Intern Med 1987;106:778.
41. Laroche R, Dupont B, Touze JE, Tealman H, Bogaerts J, Kadio A, et al. Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) in African patients: Treatment with fluconazole. J Med Vet Mycol 1992;30:71-8.
42. Berry AJ, Rinaldi MG, Graybill JR. Use of high dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS. Antimicrob Agents Chemother 1992;36:690-2.
43. Sar B, Monachy D, Vann M, Keo C, Sarthou JI, Buisson Y. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002. J Antimicrob Chemother 2004;54:563-5. Epub 2004 Jul 14.
44. Viviani MA. Opportunistic fungal infections in patients with acquired immunodeficiency syndrome. Chemotherapy 1992;38:35-42.
45. Brouwer AE, Rajanuwong A, Cheirakul W, Griffin GE, Larsen RA, White NJ, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomized trial. Lancet 2004;363:1764-7.
46. Iitaka K, McEnery PT, West CD. Successful renal transplantation after generalized cryptococcosis. J Pediatr 1978;92:422-3.
47. Stafford CR, Fisher JF, Fadel HE, Espinel-Ingroff AV, Shadomy S, Hamby M. Cryptococcal meningitis in pregnancy. Obstet Gynecol 1983;62:35s-7s.
48. Graybill JR, Sobel J, Saag M, van der Horst C, Powderly W, Cloud G, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis 2000;30:47-54.
49. Antinori S, Ridolfo AL, Gianelli E, Piazza M, Gervasoni C, Monforte AA. The role of lumbar puncture in the management of elevated intracranial pressure in patients with AIDS-associated cryptococcal meningitis. Clin Infect Dis 2000;31:1309-10.
50. Newton P, Thai LH, Tip NQ, Short JM, Chierakul W, Rajanuwong A, et al. A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis. Clin Infect Dis 2002;35:769-72.
51. Liliang PC, Liang CL, Chang WN, Chen HJ, Su TM, Lu K, et al. Shunt surgery for hydrocephalus complicating cryptococcal meningitis in human immunodeficiency virus-negative patients. Clin Infect Dis 2003;37:673-8.
52. Badour LM. with the Collaborative Exchange of Antifungal Research (CLEAR) steering committee. Early response to ABLC among patients with CNS cryptococcal infections. Blood 2000;96:438A.
53. Joly V, Aubry P, Ndayiragide A, Carrire I, Kawa E, Mlika-Cabanne N, et al. Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis. Clin Infect Dis 1996;23:556-62.
54. Bodhe PV, Kotwani RN, Kirodian BG, Kshirsagar NA, Pandya SK. Open label, randomized, comparative Phase III safety and efficacy study with conventional Amphotericin B and Liposomal Amphotericin B in patients with systemic fungal infection. JAPI 2002;50:662-70.
55. Kotwani RN, Gokhale PC, Bodhe V, Kirodan BG, Kshirsagar NA. Safety and efficacy of liposomal amphotericin B in patients with cryptococcal meningitis. J Assoc Physicians India 2001;49:1086-90.
56. Pappas PA, Bustamante B, Ticona E, Hamill RJ, Johnson PC, Reboli A, et al. Recombinant Interferon-ã1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J Infect Dis 2004;189:2185-91.
57. Powderly WG, Keath EJ, Little JR, et al. Resistant Cryptococcus neoformans in a patient with AIDS [abstract 1164]. Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Atlanta, Georgia, October 21-24, 1990.
58. Mussini C, Pezotti P, Mirü JM, Martinez E, de Quiros JC, Cinque P, et al. Discontinuation of maintainance therapy for cryptococcal meningitis in patients with AIDS treated with highly active anti retroviral therapy: an international observational study. Clin Infect Dis 2004;38:565-71.
59. Chetchotisakd P, Sungkanuparph S, Thinkhamrop B, Mootsikapun P, Boonyaprawit P. A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency. HIV Med 2004;5:140-3.
60. Chariyalertsak S, Supparatpinyo K, Sirisanthana T, Nelson KE. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. Clin Infect Dis 2002;34:277-84. Epub 2001 Dec.
61. Chacko S, John TJ, Babu PG, Jacob M, Kaur A, Mathai D. Clinical pofile of AIDS in India: a review of 61 cases. J Assoc Physicians India 1995;43:535-8.
62. Rupali P, Abraham OC, Zachariah A, Subramanian S, Mathai D. Aetiology of prolonged fever in antiretroviral-naïve human immunodeficiency virus-infected adults. Nat Med J India 2003;16:193-9.
63. Jaiswal SP, Hemwani N, Sharma N, Athale S, Chitnis DS. Prevalence of fungal meningitis among HIV positive & negative subjects in Indore (MP state). Indian J Med Sci 2002;56:325-9.
64. Kalra SP, Chadha DS, Singh AP, Sanchete PC, Mohahaptra AK. Cryptococcal meningitis in acquired immunodeficiency syndrome. J Assoc Physicians India 1999;47:958-61.
65. Khanna N, Chandramuki A, Desai A, Ravi V. Cryptococcal infection of the central nervous system: an analysis of predisposing factors, laboratory findings and outcome in patients from south India with special reference to HIV infection. J Med Microbiol 1996;45:376-9.
66. Chakrabarti A, Sharma A, Sood A, Grover R, Sakhuja V, Prabhakar S, et al. Changing scenario of cryptococcosis in a tertiary care hospital in north India. Indian J Med Res 2000;112:56-60.